Search

You searched for "therapeutics"

276 results found

Corneal Transplantation

1 February 2017 | | Cornea / External Eye Disease
This relatively small book provides a thorough overview of the history of corneal transplantation, an update on the anatomy and physiology of the cornea with particular reference to the components essential to keratoplasty procedures, also graft preparation and storage. There...
Ophthalmologica journal cover image

Rebound phenomenon after IVT triamcinolone acetonide for macular oedema

7 April 2021 | | Retina / Uvea / Vitreous | Diabetic retinopathy, Macular edema, Rebound phenomenon, Retinal vein occlusion, Triamcinolone acetonide
In this retrospective study, the authors report the rebound phenomenon after intravitreal triamcinolone acetonide (IVTA) injection for macular oedema secondary to diabetic retinopathy (DR) and central (CRVO) or branch retinal vein occlusion (BRVO). The incidence of a rebound phenomenon was...

Management of diabetic macular oedema (DMO)

1 February 2018 | | Retina / Uvea / Vitreous | Anti-VEGF therapy, Diabetic macular edema, Steroids
The authors present guidelines on current diagnostic and therapeutic procedures in the management of DMO. Fluorescein angiography (FA) and optical coherence tomography (OCT) are recommended before starting treatment to help diagnose and stage DMO, and can be repeated if there...

SPOKE launches Indicative Guidance for contact lens opticians and independent prescribers

20 February 2024 | GOC, ABDO, Optometrist, education
The Sector Partnership for Optical Knowledge and Education (SPOKE) has published two new Indicative Guidance documents.

Ophthalmic Drugs Conference 2020

23 November 2020 -24 November 2020
SMi proudly presents the 4th Annual Ophthalmic Drugs Conference taking place on 23-24 November 2020, in London.

IVTA use in Behçet’s disease

1 April 2014 | | Ocular Pathology and Oncology
This study aimed to evaluate the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) injection (4mg/0.1ml) in controlling posterior segment inflammation in patients with Behçet’s disease. Medical records of consecutive patients diagnosed with Behçet’s who underwent IVTA between July 2005...

Eye research: where next?

1 December 2017 | | Cornea / External Eye Disease, Cataract and Refractive, Glaucoma, Genetics, Imaging, Neuro-Ophthalmology, Ocular Pathology and Oncology, Oculoplastics, Ophthalmology, Optometry, Orbit, Paediatric Ophthalmology / Strabismus, Retina / Uvea / Vitreous, AMD, Emergency Ophthalmology
Eye research in the UK is underfunded relative to other areas of medical research and general awareness of sight loss and its prevention remains poor, messages that were reinforced in presentations and discussions during a recent research summit meeting in...

Birdshot retinochoroiditis

1 June 2022 | | Ophthalmology, Retina / Uvea / Vitreous
Birdshot retinochoroiditis (BRC) is a chronic, sight-threatening uveitis, most commonly affecting caucasian individuals in their fourth to sixth decades [1]. The disease is associated with HLA-29 and is characterised by progressive inflammation at the level of retina and choroid, with...

Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions

1 August 2018 | | Ophthalmology
Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...

An update on idiopathic intracranial hypertension

1 August 2017 | | Neuro-Ophthalmology
The incidence of Idiopathic intracranial hypertension (IIH) is increasing, likely in line with the worldwide epidemic of obesity. To date, there have been revisions in the terminology used and diagnostic criteria for IIH; these recognise the need to exclude secondary...

Conservative management of concomitant strabismus

1 October 2019 | | Optometry
The aim of management for all patients with strabismus should centre around four goals: to prevent amblyopia, to alleviate symptoms, to restore binocular single vision (BSV) and to improve ocular alignment. The conservative management options available for strabismus include observation,...

My top five: Innovative approaches to dry AMD

2 February 2024 | | AMD
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the developing world with its prevalence rising alongside age. In societies characterised by ageing populations, it is imperative we explore more effective treatment to alleviate the...